PERSPECTA

News from every angle

Back to headlines

Nicox Sets April 2027 Regulatory Deadline for Glaucoma Drug NCX 470

Biotech firm Nicox has announced that the US FDA has scheduled a Prescription Drug User Fee Act (PDUFA) date of April 2027 for its novel glaucoma treatment, NCX 470.

27 Aug, 05:30 — 27 Aug, 05:30
PostShare